CTRI/2025/09/094101尚未招募4 期
Comparison of Efficacy and Safety of 308 nm Excimer laser and Intralesional Triamcinolone in treating Alopecia Areata
Dr. Khushboo Ajaykumar Heda1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2025年9月15日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- Patients with more than 50% hair regrowth will be considered successful treatment.
研究概览
简要总结
While both 308 nm Excimer laser therapy and intralesional triamcinolone injections have shown efficacy in the treatment of alopecia areata, there is a lack of direct comparative studies evaluating their effectiveness. Further research is needed to determine the optimal treatment approach for alopecia areata based on efficacy, safety, and patient preferences.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 7.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients who give consent for the study
- •Age more than 7 years and less than 60 years
- •Patients with a diagnosis of patch type of alopecia areata
- •Patients presenting with less than 5 patches sizes 2cm to 5cm.
- •Subjects having patch for atleast 3 months with no evidence of hair regrowth
- •Patients who have never taken treatment or who have not taken treatment for atleast 8 weeks
- •Patients who are willing and capable of cooperating to the extent and degree required by the protocol.
排除标准
- •Patients who do not give consent.
- •Patients who received treatment within last 8 weeks.
- •Patients with alopecia totalis or alopecia universalis.
- •Patients with known photosensitivity like polymorphous light eruption, connective tissue diseases, porphyria, xeroderma pigmentosum.
- •Pregnant or breast feeding.
- •History of previous skin cancer.
- •Patient with history of existing skin disease affecting the scalp such as psoriasis.
结局指标
主要结局
Patients with more than 50% hair regrowth will be considered successful treatment.
时间窗: 12 weeks
Response to treatment is graded according to therapeutic efficacy which is calculated using Severity of Alopecia tool score (SALT).
时间窗: 12 weeks
次要结局
- 1. Treatment outcome rates
研究者
Dr Khushboo Ajaykumar Heda
Vilasrao Deshmukh Government Medical College, Latur
研究点 (1)
Loading locations...
相似试验
招募中
4 期
Comparing the Efficacy and Safety of Holmium Laser Lithotripsy Versus Electrohydraulic Lithotripsy for the Treatment of Difficult Choledocholithiasis and Pancreatic Duct StonesNCT07418112Rush University Medical Center40
尚未招募
4 期
TO EVALUATE THE EFFECTIVENESS OF LOW LEVEL LASER THERAPY (LLLT) USING 810nm DIODE LASER ON IMPLANT STABILITY MEASURED BY RESONANCE FREQUENCY ANALYSIS (RFA)— A RANDOMIZED CONTROLLED CLINICAL TRIALCTRI/2026/01/100334J.N Kapoor DAV (c) Dental College20
招募中
不适用
Facial Papules in Frontal Fibrosing Alopecia (FFA)NCT07340671University of Miami10
招募中
2 期
Study to assess the safety and efficacy of the SpectraCure P18 System2022-502285-24-00SpectraCure AB (publ), SpectraCure AB (publ)26
尚未招募
2 期
A phase 2 study of the efficacy of intratumorally administered L19IL2 or L19TNF or L19IL2/L19TNF, all in combination with systemic anti-PD1 Pembrolizumab, in stage III/IV unresectable melanoma patients with resistance to anti-PD1 checkpoint inhibitors (INTACT / MeRCI)2024-519326-20-00Philogen S.p.A.25